Back to video list Back to Home COVID-19 & MDD: Current challenges and implications for clinical practice You may also like Schizophrenia Bipolar Article Can neuroimaging lead to the development of biomarkers in schizophrenia? Schizophrenia Article Steps towards more effective and better tolerated treatment options for schizophrenia Depression Article Innovation and tailored treatments drive improved outcomes in depression Depression video Interview Defining what ‘first-line antidepressant’ means to physicians